Karl Balabanian

22PUBLICATIONS
134CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityAutoimmunityMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Dec 12, 2025
A circadian checkpoint relocates neutrophils to minimize injury.

Alejandra Aroca-Crevillén, Sandra Martín-Salamanca, Lidiane S Torres

|Jul 29, 2025
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.

Paul Breillat, Francesco Carbone, Emilie Lereclus

|Nov 21, 2024
Inflammatory Waldenström macroglobulinemia is associated with clonal hematopoiesis: a multicentric cohort.

Pierre-Edouard Debureaux, Stéphanie Poulain, Stéphanie Harel

|Oct 29, 2024
CXCR4 signaling determines the fate of hematopoietic multipotent progenitors by stimulating mTOR activity and mitochondrial metabolism.

Vincent Rondeau, Maria Kalogeraki, Lilian Roland

|Apr 10, 2024
CXCR4 Antagonist in HPV5-Associated Perianal Squamous-Cell Carcinoma.

Viviana Marin-Esteban, Lucie Molet, Marta Laganà

|Dec 20, 2023
Lymphopenia confers poorer prognosis in Myelodysplastic Syndromes with very low and low IPSS-M.

David Fandrei, Tony Huynh, Marie Sébert

Pageof 4

Frequent Collaborators

8 joint publications

Nicolas Dulphy

8 joint publications

Marion Espéli

5 joint publications

Lin-Pierre Zhao

4 joint publications

David H McDermott